Neuropace Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Neuropace Inc 's inventory turnover ratio, the ratio that measures Neuropace Inc 's ability to manage its supply chain, sequentially decreased to 1.23 in the first quarter 2026, which does not come as a surprise, as the Neuropace Inc continue to experience headwinds, which also impact its supply chain. Neuropace Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 297 days, from 270 days, in the Dec 31 2025 quarter.

Within Healthcare sector 289 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1326 in the fourth quarter 2025, to 1636.

NPCE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Neuropace Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NPCE Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	22.93 %	26.27 %	50.07 %	43.85 %	18.96 %
Y / Y Cost of Sales Growth	-20 %	0 %	20 %	0 %	25 %
Inventory Turnover Ratio (TTM)	1.23	1.35	1.43	1.52	1.67
NPCE's Total Ranking	# 1636	# 1326	# 1089	# 1301	# 1084
Average inventory processing period	296	269	255	241	219
Seq. Inventory Growth	-1.2 %	-6.83 %	10.94 %	20.37 %	1.49 %
Seq. Cost of Sales Growth	-33.33 %	0 %	20 %	0 %	-16.67 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 133
Healthcare Sector	# 290
Overall Market	# 1636

Inventory Turnover Ratio Statistics
High	Average	Low
1.67	1.53	1.23
(Mar 31 2025)		(Mar 31 2026)

NPCE Company Profile >> Back to NPCE Efficiency Comparisons >> Compare NPCE Inventory Turnover Ratio to its Competitors

Financial Statements
Neuropace Inc 's Inventories	$ 17 Millions	Visit NPCE's Balance sheet
Neuropace Inc 's Cost of Revenues TTM	$ 21 Millions	Visit NPCE's Income Statement
What are NPCE's Sales?		Visit NPCE's Sales by Segment

Other Inventory Turnover Ratios
Neuropace Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NPCE's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NPCE's Competitors
Inventory Turnover Ratio for NPCE's Suppliers
Inventory Turnover Ratio for NPCE's Customers

You may also want to know
NPCE's Sales Growth Rates	NPCE's Pe Price to earnings ratio	NPCE's Receivables Turnover Ratio	NPCE's Stock Quote
NPCE's Net Income Growth Rates	NPCE's Ps Price to Sales ratio	NPCE's Sales per Employee	NPCE's Asset Turnover Ratio
NPCE's Net Margin	NPCE's Pb Price to Book ratio	NPCE's Financial Strength Ratios	NPCE's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Tandem Diabetes Care Inc	3.45	$ 461.746 Millions	$ 134 Millions
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions
Maravai Lifesciences Holdings Inc	3.33	$ 143.875 Millions	$ 43 Millions
Intelligent Bio Solutions Inc	3.31	$ 2.064 Millions	$ 1 Millions
Agilent Technologies inc	3.29	$ 3,418.000 Millions	$ 1,038 Millions
Cadre Holdings inc	3.28	$ 372.000 Millions	$ 113 Millions
Solventum Corporation	3.23	$ 3,363.000 Millions	$ 1,042 Millions
Biofrontera Inc	3.22	$ 8.867 Millions	$ 3 Millions
10x Genomics Inc	3.21	$ 193.000 Millions	$ 60 Millions
Iovance Biotherapeutics inc	3.14	$ 165.941 Millions	$ 53 Millions
Lftd Partners Inc	3.12	$ 28.258 Millions	$ 9 Millions
Prestige Consumer Healthcare Inc	3.11	$ 493.000 Millions	$ 159 Millions
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions
Bausch Health Companies Inc	3.07	$ 2,987.000 Millions	$ 974 Millions
Indivior Pharmaceuticals Inc	3.03	$ 242.000 Millions	$ 80 Millions
Amneal Pharmaceuticals Inc	3.02	$ 1,868.000 Millions	$ 618 Millions
Logicmark Inc	3.01	$ 3.826 Millions	$ 1 Millions
Mettler toledo International Inc	3.01	$ 1,189.678 Millions	$ 395 Millions
Revvity Inc	3.00	$ 1,151.379 Millions	$ 384 Millions
Cannapharmarx Inc	2.98	$ 2.921 Millions	$ 1 Millions
Becton Dickinson And Company	2.97	$ 11,368.000 Millions	$ 3,821 Millions
Dexcom Inc	2.97	$ 1,854.000 Millions	$ 624 Millions
Msa Safety Inc	2.93	$ 1,020.000 Millions	$ 349 Millions
Nexgel Inc	2.92	$ 6.000 Millions	$ 2 Millions
Abbott Laboratories	2.91	$ 19,741.000 Millions	$ 6,785 Millions
Zai Lab Limited	2.91	$ 128.112 Millions	$ 44 Millions
Mimedx Group Inc	2.87	$ 74.000 Millions	$ 26 Millions
Dentsply Sirona Inc	2.82	$ 1,880.000 Millions	$ 666 Millions

Date modified: 2026-08-30T15:01:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.